In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.

Health officials said the decision was taken to use tribal languages after facing challenges in communicating health messages in the remote tribal belts.

After 35 years of consistent pain, Allan Byamukama became one of the few individuals in the world cured of sickle cell ...

Sickle cell patients are fighting to save a specialist NHS unit they rely on during pain crises, warning that A&E delays and ...

The Sickle Cell Day Unit at the Royal London Hospital in Whitechapel, London, remains under threat following a temporary six-month trial, prompting sustained opposition from patients, families, and ...

When it was announced in 2023 that the world’s first Crispr-based gene-editing therapy had been approved in the UK there was ...

The lifelong effects of rare blood disorder diagnoses in childhood are being analysed in a first-of-its-kind study led by the ...

What you need to know: Sickle cell disease (SCD) remains one of Uganda’s most silent epidemics, affecting thousands of children across the country, yet its impact is often underreported and ...

Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...

Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

US based cooking expert Yewande Komolafe tells the story of her battle with sickle cell and recounts her journey back to ...